CELESTIAL

The Exchange has sought clarification from Celestial Biolabs Limited for the quarter ended 31-Mar-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted -2. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.

The Exchange has sought clarification from Celestial Biolabs Limited for the quarter ended 31-Dec-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.

The Exchange has sought clarification from Celestial Biolabs Limited for the quarter ended 30-Sep-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.

The Exchange has sought clarification from Celestial Biolabs Limited for the quarter ended 30-Jun-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended March 31, 2023.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended June 30, 2023.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2023.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended December 31, 2023.

The Exchange had sought clarification from Celestial Biolabs Limited for the quarter ended 31-Dec-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Segment details not submitted -2. Consolidated Financial Results not submitted The response of the Company is enclosed.

The Exchange has sought clarification from Celestial Biolabs Limited for the quarter ended 31-Dec-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted -2. Consolidated Financial Results not submitted The response of the Company is awaited.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended December 31, 2022.

��The Exchange had sought clarification from Celestial Biolabs Limited with respect to Financial Results dated 14-Nov-2022 for the period Sep, 2022On the basis of aforesaid disclosure, the Listed entity was required to clarify the following:1.Standalone: Segment Reporting - Not found. The response of the company is attached.

The Exchange has sought clarification from Celestial Biolabs Limited with respect to Financial Results dated 14-Nov-2022 for the period Sep, 2022On the basis of aforesaid disclosure, the Listed entity is required to clarify the following:1.Standalone: Segment Reporting - Not foundThe response of the company is awaited

The Exchange has sought clarification from Celestial Biolabs Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. No Segment Reporting. The response of the Company is awaited.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended June 30, 2019.

The Exchange has sought clarification from Celestial Biolabs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. No Segment Reporting. -2. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. -3. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.

Celestial Biolabs Limited has informed the Exchange regarding Reasons for Delayed/Non-submission of Financial Results.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended March 31, 2019.

The Exchange had sought clarification from Celestial Biolabs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Standalone limited review report not submitted. The response of the Company is enclosed.

The Exchange has sought clarification from Celestial Biolabs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Standalone limited review report not submitted. The response of the Company is awaited.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended December 31, 2018.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2018.

The Exchange had sought clarification from Celestial Biolabs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI -2. Financial results not signed by authorized signatory/ies -3. Standalone limited review report not submitted. The response of the Company is enclosed.

The Exchange has sought clarification from Celestial Biolabs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI -2. Financial results not signed by authorized signatory/ies -3. Standalone limited review report not submitted. The response of the Company is awaited.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended June 30, 2018.

The Exchange had sought clarification from Celestial Biolabs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013. -2. Standalone audited report not submitted. -3. Board meeting notice not submitted. -4. Standalone Reconciliation of Equity not submitted -5. The company has not submitted the Statement of Modified Opinion or in case

The Exchange has sought clarification from Celestial Biolabs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013. -2. Standalone audited report not submitted. -3. Board meeting notice not submitted. -4. Standalone Reconciliation of Equity not submitted- 5. The company has not submitted the Statement of Modified Opinion or in case o

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended 31-Mar-2018.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended 31-Dec-2017.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended 30-Sep-2017.

The Exchange had sought clarification from Celestial Biolabs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results not submitted within 30 minutes from end of board meeting. -2. Financial results not submitted as per Schedule III to the Companies Act, 2013 -3. Standalone limited review report not submitted. -4. Reconciliation of profit and loss not submitted. The response of the Company is enclosed.

The Exchange has sought clarification from Celestial Biolabs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify. -1. Reconciliation of profit and loss not submitted. -2. Standalone limited review report not submitted. -3. Financial results not submitted as per Schedule III to the Companies Act, 2013 -4. Financial results not submitted within 30 minutes from end of board meeting. The response of the Company is awaited.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended 30-Jun-2017.

Celestial Biolabs Limited has informed the Exchange regarding Financial Results Updates

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended 31-Mar-2017.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended 31-Dec-2016.

Celestial Biolabs Limited has submitted to the Exchange, the financial results for the period ended 30-Sep-2016.

Celestial Biolabs Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended 30-Jun-2016.

Celestial Biolabs Limited has submitted to the Exchange the standalone financial results along with the Auditors Report for the period ended March 31, 2016.

Celestial Biolabs Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended December 31, 2015.

Celestial Biolabs Limited has submitted to the exchange the standalone financial results for the period ended 30-Sep-2015.

Celestial Biolabs Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Jun-2015.

Celestial Biolabs Limited has submitted to the exchange the standalone financial results for the period ended 31-Mar-2015.

Celestial Biolabs Limited has submitted to the exchange the standalone financial results for the period ended 31-Dec-2014.

Celestial Biolabs Limited has submitted to the exchange the standalone financial results for the period ended 30-Sep-2014.

Celestial Biolabs Limited has submitted to the exchange the standalone financial results for the period ended 30-Jun-2014.

Celestial Biolabs Limited has submitted to the exchange the standalone financial results for the period ended 31-Mar-2014.

Celestial Biolabs Limited has submitted to the exchange the standalone financial results for the period ended 31-Dec-2013.

Celestial Biolabs Limited has submitted to the exchange the standalone financial results for the period ended 30-Sep-2013.

Celestial Biolabs Limited has submitted to the Exchange the Standalone Financial Results for the period ended June 30,2013.